OLIVIA SIMPSON: Open Payments
NPI 1497214654 · MOULTRIE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 30 payments from 12 companies in 2025. Trend: 2023 $131 · 2024 $2,919 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $222 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $111 |
| Vital Connect, Inc | 2 | $61 |
| Novo Nordisk Inc | 3 | $59 |
| BridgeBio Pharma, Inc. | 2 | $42 |
| SCPHARMACEUTICALS INC. | 2 | $36 |
| Kestra Medical Technology Services, Inc. | 2 | $27 |
| Philips North America LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Medtronic, Inc. | 1 | $18 |
Products named: LEQVIO, Kerendia, VITALPATCH RTM, Wegovy, Attruby, FUROSCIX, Assure WCD, ENTRESTO.
Industry payments across GA — which companies pay providers there.
